MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
2026: MFN Program Grows to 26 Drugmakers as Nine More Commit to $19.6B in US Manufacturing
Attachments
mfn-program-nine-drugmakers-manufacturing-investment
Parents
*Driving Forces: BioPharmaceuticals _ Biotechnology, Genomics, Genetics, Bioinformatics, Biomanufacturing & Personalized Medicine, Drug Discovery, Development & Delivery
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
Children
AbbVie Inc. (NYSE:ABBV)
Amgen Inc. (NASDAQ:AMGN)
AstraZeneca PLC (NASDAQ:AZN)*
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company (NYSE:BMY)
Eli Lilly and Company (NYSE: LLY)*
Genentech, Inc., (NYSE:DNA) #1 Largest Biotechnology Company
Gilead Sciences, Inc. (NASDAQ: GILD)*
GlaxoSmithKline plc (GSK)
Johnson & Johnson, Inc. [J&J] (NYSE:JNJ)*
Merck & Co., Inc. (NYSE:MRK)
Merck Serono, emd Serono
Novartis AG (NYSE: NVS)*
Novo Nordisk A/S (NYSE:NVO)
Pfizer Inc. (NYSE: PFE)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Sanofi-Aventis SA (NYSE: SNY)
Jumps
2026: White House unveils next round of MFN pricing deals with 9 midsized drugmakers